Literature DB >> 16855821

Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi.

R M Santa-Rita1, H S Barbosa, S L de Castro.   

Abstract

We have previously reported that epimastigote forms of Trypanosoma cruzi treated with the lysophospholipid analogues (LPAs) edelfosine (ET-18), ilmofosine, and miltefosine suffered alterations in plasma membrane, mitochondrion, and lipid synthesis. In this work, ET-18 induced membrane damage in trypomastigotes and amastigotes. Incubation of epimastigotes and trypomastigotes with the three LPAs led to membrane permeabilization, which was abolished by serum addition. Treatment for 24 h in culture medium interfered the with mitochondrial status of epimastigotes, with no effect in trypomastigotes, in agreement with ultrastructural data. LPAs induced alterations in the plasma membrane of the three forms of T. cruzi and in the mitochondria of epimastigotes, suggesting that these organelles are potential targets of these analogues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855821     DOI: 10.1007/s00436-006-0250-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  15 in total

1.  Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi.

Authors:  Victor B Saraiva; Daniel Gibaldi; José O Previato; Lucia Mendonça-Previato; Marcelo T Bozza; Célio G Freire-De-Lima; Norton Heise
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi.

Authors:  R M Santa-Rita; H Santos Barbosa; M N Meirelles; S L de Castro
Journal:  Acta Trop       Date:  2000-03-25       Impact factor: 3.112

3.  Effect of alkyl-lysophospholipid analogs on the morphology of a murine lymphoma cell line.

Authors:  D Vagnetti; A Mancini; B Santarella; L Binaglia
Journal:  J Submicrosc Cytol Pathol       Date:  1990-07

4.  The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.

Authors:  S L Croft; D Snowdon; V Yardley
Journal:  J Antimicrob Chemother       Date:  1996-12       Impact factor: 5.790

5.  Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.

Authors:  Ricardo M Santa-Rita; Andréa Henriques-Pons; Helene S Barbosa; Solange L de Castro
Journal:  J Antimicrob Chemother       Date:  2004-08-25       Impact factor: 5.790

6.  Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.

Authors:  R Andreesen; M Modolell; G H Oepke; H Common; G W Löhr; P G Munder
Journal:  Anticancer Res       Date:  1982 Jan-Apr       Impact factor: 2.480

7.  Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study.

Authors:  A Noseda; J G White; P L Godwin; W G Jerome; E J Modest
Journal:  Exp Mol Pathol       Date:  1989-02       Impact factor: 3.362

8.  Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.

Authors:  E S Petersen; E E Kelley; E J Modest; C P Burns
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

Review 9.  Antiprotozoal lysophospholipid analogues: a comparison of their activity against trypanosomatid parasites and tumor cells.

Authors:  S L de Castroa; R M Santa-Ritaa; J A Urbinab; S L Croftc
Journal:  Mini Rev Med Chem       Date:  2004-02       Impact factor: 3.862

10.  The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.

Authors:  M Lohmeyer; P Workman
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

View more
  9 in total

Review 1.  Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.

Authors:  Cristina Fonseca-Berzal; Vicente J Arán; José A Escario; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2018-09-19       Impact factor: 2.289

2.  An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1.

Authors:  Neeloo Singh; Jaspreet Kaur; Pranav Kumar; Swati Gupta; Nasib Singh; Angana Ghosal; Avijit Dutta; Ashutosh Kumar; Ramapati Tripathi; Mohammad Imran Siddiqi; Chitra Mandal; Anuradha Dube
Journal:  Parasitol Res       Date:  2009-07-21       Impact factor: 2.289

3.  Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.

Authors:  Juan Román Luque-Ortega; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

4.  Evaluation of the effect of miltefosine on Trichomonas vaginalis.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2013-12-22       Impact factor: 2.289

5.  In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi.

Authors:  Cristiane França da Silva; Marcos Meuser Batista; Denise da Gama Jaen Batista; Elen Mello de Souza; Patrícia Bernardino da Silva; Gabriel Melo de Oliveira; Andrea Souza Meuser; Abdur-Rafay Shareef; David W Boykin; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

6.  Cellular effects of reversed amidines on Trypanosoma cruzi.

Authors:  C F Silva; M B Meuser; E M De Souza; M N L Meirelles; C E Stephens; P Som; D W Boykin; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

7.  4-Acetoxydolastane diterpene from the Brazilian brown alga Canistrocarpus cervicornis as antileishmanial agent.

Authors:  Adriana Oliveira Dos Santos; Elizandra Aparecida Britta; Everson Miguel Bianco; Tania Ueda-Nakamura; Benedito Prado Dias Filho; Renato Crespo Pereira; Celso Vataru Nakamura
Journal:  Mar Drugs       Date:  2011-11-11       Impact factor: 6.085

8.  Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors.

Authors:  Leandro Stefano Sangenito; Claudia Masini d'Avila-Levy; Marta Helena Branquinha; André Luis Souza Dos Santos
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-16       Impact factor: 2.743

9.  Soulamarin isolated from Calophyllum brasiliense (Clusiaceae) induces plasma membrane permeabilization of Trypanosoma cruzi and mytochondrial dysfunction.

Authors:  Alexandre Rea; Andre G Tempone; Erika G Pinto; Juliana T Mesquita; Eliana Rodrigues; Luciana Grus M Silva; Patricia Sartorelli; João Henrique G Lago
Journal:  PLoS Negl Trop Dis       Date:  2013-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.